Urgent strategies needed to fight artemisinin resistance in East Africa

FHS
July 19, 2024
5:01 am

Artemisinin-based combination therapies (ACTs) have become the cornerstone of malaria treatment and control.

Gene editing has had a big week in the spotlight. Here’s what’s going on

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here

November 1, 2023

Study predicts major rise in deaths due to extreme temperatures and air pollution

New study projects a sharp rise in temperature- and pollution-related mortality, with the impact of temperature surpassing that of pollution for a fifth of the

November 21, 2024

OrbiMed raises $4.3B across three funds to invest in biotech companies, as well as royalty deals and China startups

OrbiMed said Tuesday it has raised over $4.3 billion across three new funds to invest in public and private biotechs amid a lengthy market downturn.

October 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.